38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Diamorphine hydrochloride 100 mg powder for solution for injection ampule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Diamorphine hydrochloride 100 mg powder for solution for injection ampule	Count of base of active ingredient	False	un	Inferred relationship	Some
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Doxorubicin hydrochloride 10 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Doxorubicin hydrochloride 10 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
ceftazidime 1 g, pour injection (poudre pour reconstitution)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
ceftazidime 1 g, pour injection (poudre pour reconstitution)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ceftazidime 1 g, pour injection (poudre pour reconstitution)	Count of base of active ingredient	False	un	Inferred relationship	Some
Disodium pamidronate 90 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Disodium pamidronate 90 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Disodium pamidronate 30 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Disodium pamidronate 30 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ceftazidime 250 mg, flacon de poudre pour solution injectable	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ceftazidime 250 mg, flacon de poudre pour solution injectable	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Deferoxamine mesilate 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Deferoxamine mesilate 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Deferoxamine mesilate 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Deferoxamine mesilate 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Colistimethate sodium 500000 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Colistimethate sodium 500000 unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Amifostine 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amifostine 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
ceftazidime 500 mg, pour injection (poudre pour reconstitution)	Count of base of active ingredient	False	un	Inferred relationship	Some
ceftazidime 500 mg, pour injection (poudre pour reconstitution)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Clarithromycin 250 mg granules for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Clarithromycin 250 mg granules for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Amifostine 375 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amifostine 375 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
ceftazidime 2 g, pour injection (poudre pour reconstitution)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ceftazidime 2 g, pour injection (poudre pour reconstitution)	Count of base of active ingredient	False	un	Inferred relationship	Some
Botulinum toxin type A 500 unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Botulinum toxin type A 500 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Benzylpenicillin sodium 600 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Benzylpenicillin sodium 600 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Epirubicin hydrochloride 10 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Epirubicin hydrochloride 10 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Agalsidase beta 35 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Agalsidase beta 35 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 69 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module